{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Foreign", "lead_paragraph": "The government\u2019s $1.3 billion program to stop H.I.V. infection in Africa is not cost effective, a new study by a Stanford student shows.", "headline": {"main": "U.S. Push for Abstinence in Africa Is Seen as Failure Against H.I.V.", "print_headline": "American H.I.V. Battle in Africa Is Said to Falter"}, "abstract": "Study conducted by Stanford Medical School student Nathan Lo finds that $1.3 billion America has spent since 2005 to stop HIV infection in Africa through abstinence and fidelity was largely wasted.", "print_page": "12", "word_count": "805", "_id": "54efd8bc798810693c97d497", "snippet": "The government\u2019s $1.3 billion program to stop H.I.V. infection in Africa is not cost effective, a new study by a Stanford student shows.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/02/27/health/american-hiv-battle-in-africa-said-to-falter.html", "multimedia": [], "subsection_name": null, "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Stanford University", "is_major": "N", "rank": "11", "name": "organizations"}, {"value": "Africa", "is_major": "Y", "rank": "2", "name": "glocations"}, {"value": "Lo, Nathan", "is_major": "N", "rank": "3", "name": "persons"}, {"value": "Global Fund to Fight AIDS, Tuberculosis and Malaria", "is_major": "N", "rank": "4", "name": "organizations"}, {"value": "Research", "is_major": "N", "rank": "5", "name": "subject"}, {"value": "Abstinence (Sexual)", "is_major": "N", "rank": "6", "name": "subject"}, {"value": "United States", "is_major": "N", "rank": "7", "name": "glocations"}, {"value": "Sex", "is_major": "N", "rank": "8", "name": "subject"}, {"value": "President's Emergency Plan for AIDS Relief", "is_major": "N", "rank": "9", "name": "organizations"}, {"value": "Bush, George W", "is_major": "N", "rank": "10", "name": "persons"}], "byline": {"person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2015-02-27T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "National", "lead_paragraph": "Scientists at an AIDS conference in Seattle said paying patients as much as $280 a year to take AIDS-prevention drugs failed to significantly improve adherence or infection rates.", "headline": {"main": "Study That Paid Patients to Take H.I.V. Drugs Fails ", "print_headline": "Study That Paid Patients to Take H.I.V. Drugs Fails"}, "abstract": "Study conducted by AIDS expert Dr Wafaa M El-Sadr finds that cash incentives have been ineffective in motivating patients to adhere to their HIV medication regimen.", "print_page": "12", "word_count": "1079", "_id": "54ecfc7979881019c721dd50", "snippet": "Scientists at an AIDS conference in Seattle said paying patients as much as $280 a year to take AIDS-prevention drugs failed to significantly improve adherence or infection rates.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/02/25/health/cash-payments-fail-to-improve-hiv-drug-adherence-researchers-say.html", "multimedia": [{"subtype": "wide", "url": "images/2015/02/25/us/24HIV/24HIV-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/02/25/us/24HIV/24HIV-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/02/25/us/24HIV/24HIV-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/02/25/us/24HIV/24HIV-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/02/25/us/24HIV/24HIV-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/02/25/us/24HIV/24HIV-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Acquired Immune Deficiency Syndrome", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "2", "name": "subject"}, {"value": "Medicine and Health", "is_major": "N", "rank": "3", "name": "subject"}], "byline": {"person": [{"qualifier": "Jr", "firstname": "Donald", "middlename": "G.", "lastname": "McNEIL", "rank": 1, "role": "reported", "organization": ""}], "original": "By DONALD G. McNEIL Jr"}, "document_type": "article", "pub_date": "2015-02-25T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Business", "lead_paragraph": "The strategy for a new drug to treat binge-eating disorder reveals how a pharmaceutical company can influence the treatment of a medical condition.", "headline": {"main": "Shire, Maker of Binge-Eating Drug Vyvanse, First Marketed the Disease", "print_headline": "Maker of a Drug to Treat Binge-Eating Marketed the Disease First"}, "abstract": "Some critics say drug maker Shire is going too far in its marketing of Vyvanse, amphetamine-based drug that was recently approved to treat binge-eating disorder; Shire spent years before approval shaping public perception and diagnosis of binge-eating disorder, much as it did with ADHD in the past; controversy highlights marketing strategy that has yielded billions in profits and that many say presents public danger.", "print_page": "1", "word_count": "1347", "_id": "54ecb2d779881019c721dc4e", "snippet": "The strategy for a new drug to treat binge-eating disorder reveals how a pharmaceutical company can influence the treatment of a medical condition.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2015/02/25/business/shire-maker-of-binge-eating-drug-vyvanse-first-marketed-the-disease.html", "multimedia": [{"subtype": "wide", "url": "images/2015/02/25/business/25BINGE1/25BINGE1-thumbWide.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/02/25/business/25BINGE1/25BINGE1-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/02/25/business/25BINGE1/25BINGE1-articleLarge.jpg", "height": 400, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/02/25/business/25BINGE1/25BINGE1-articleLarge.jpg", "xlargeheight": "400"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/02/25/business/25BINGE1/25BINGE1-thumbStandard.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/02/25/business/25BINGE1/25BINGE1-thumbStandard.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Shire PLC", "is_major": "Y", "rank": "1", "name": "organizations"}, {"value": "Eating Disorders", "is_major": "Y", "rank": "3", "name": "subject"}, {"value": "Advertising and Marketing", "is_major": "Y", "rank": "4", "name": "subject"}, {"value": "Drugs (Pharmaceuticals)", "is_major": "Y", "rank": "5", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "Y", "rank": "6", "name": "organizations"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Katie", "lastname": "THOMAS"}], "original": "By KATIE THOMAS"}, "document_type": "article", "pub_date": "2015-02-25T00:00:00Z", "section_name": "Business Day"}, {"type_of_material": "Blog", "blog": [], "news_desk": "Science", "lead_paragraph": null, "headline": {"main": "Need to Curtail Smoking Becomes More Acute as Its Known Dangers Widen", "kicker": "Well", "print_headline": "More Worries Rise From the Ashes"}, "abstract": "A study linking an extra five diseases and 60,000 deaths to tobacco use, and the popularity of e-cigarettes, should push the F.D.A. into action.", "print_page": null, "word_count": "964", "_id": "54eb054e7988102c57355c52", "snippet": "A study linking an extra five diseases and 60,000 deaths to tobacco use, and the popularity of e-cigarettes, should push the F.D.A. into action.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://well.blogs.nytimes.com/2015/02/23/need-to-curtail-smoking-becomes-more-acute-as-its-known-dangers-widen/", "multimedia": [{"subtype": "wide", "url": "images/2015/02/24/science/24BRODY/24BRODY-thumbWide-v2.jpg", "height": 126, "width": 190, "legacy": {"wide": "images/2015/02/24/science/24BRODY/24BRODY-thumbWide-v2.jpg", "wideheight": "126", "widewidth": "190"}, "type": "image"}, {"subtype": "xlarge", "url": "images/2015/02/24/science/24BRODY/24BRODY-articleLarge-v2.jpg", "height": 481, "width": 600, "legacy": {"xlargewidth": "600", "xlarge": "images/2015/02/24/science/24BRODY/24BRODY-articleLarge-v2.jpg", "xlargeheight": "481"}, "type": "image"}, {"subtype": "thumbnail", "url": "images/2015/02/24/science/24BRODY/24BRODY-thumbStandard-v2.jpg", "height": 75, "width": 75, "legacy": {"thumbnailheight": "75", "thumbnail": "images/2015/02/24/science/24BRODY/24BRODY-thumbStandard-v2.jpg", "thumbnailwidth": "75"}, "type": "image"}], "subsection_name": null, "keywords": [{"value": "Smoking and Tobacco", "is_major": "Y", "rank": "1", "name": "subject"}, {"value": "Food and Drug Administration", "is_major": "N", "rank": "2", "name": "organizations"}, {"value": "American Cancer Society", "is_major": "N", "rank": "3", "name": "organizations"}, {"value": "Emphysema", "is_major": "N", "rank": "4", "name": "subject"}, {"value": "E-Cigarettes", "is_major": "N", "rank": "5", "name": "subject"}], "byline": {"person": [{"firstname": "Jane", "middlename": "E.", "lastname": "BRODY", "rank": 1, "role": "reported", "organization": ""}], "original": "By JANE E. BRODY"}, "document_type": "blogpost", "pub_date": "2015-02-23T05:45:08Z", "section_name": "Health"}], "meta": {"hits": 4, "offset": 0, "time": 36}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}